Performance of Binax NOW Flu A and B and direct fluorescent assay in comparison with a composite of viral culture or reverse transcription polymerase chain reaction for detection of influenza infection during the 2006 to 2007 season

Mahbubur Rahman, Mary F. Vandermause, Burney A. Kieke, Edward A. Belongia

    Research output: Contribution to journalArticle

    38 Citations (Scopus)

    Abstract

    The Binax NOW Flu A and Flu B (Binax NOW), direct fluorescent assay (DFA), and viral culture were evaluated and compared with a composite of viral culture or reverse transcription polymerase chain reaction (RT-PCR). Participants with medically attended acute respiratory illness were identified through active surveillance during the 2006 to 2007 season, and consenting individuals (n = 932) were tested for influenza by culture and RT-PCR. Physicians ordered a rapid antigen test (Binax NOW [n = 73] or DFA [n = 70]) according to their clinical judgment. The Binax NOW detected 11 of 18 influenza infections (sensitivity, 61%; 95% confidence interval [CI], 36-83%), whereas DFA detected 17 of 21 influenza infections (sensitivity 81%, 95% CI, 58-95%). Compared with culture/RT-PCR, specificity of both Binax NOW and DFA was 100%. During the 2006 to 2007 influenza season, DFA and Binax NOW demonstrated high specificity but failed to identify a substantial proportion of influenza infections.

    Original languageEnglish (US)
    Pages (from-to)162-166
    Number of pages5
    JournalDiagnostic Microbiology and Infectious Disease
    Volume62
    Issue number2
    DOIs
    StatePublished - Oct 2008

    Fingerprint

    Human Influenza
    Reverse Transcription
    Polymerase Chain Reaction
    Infection
    Confidence Intervals
    Physicians
    Antigens

    Keywords

    • Binax NOW
    • Direct fluorescent assay
    • Influenza virus
    • Rapid test
    • Sensitivity
    • Specificity

    ASJC Scopus subject areas

    • Infectious Diseases
    • Immunology and Allergy
    • Virology
    • Parasitology
    • Microbiology
    • Immunology
    • Applied Microbiology and Biotechnology

    Cite this

    @article{b2694b02b4b44020ab86e715675f02db,
    title = "Performance of Binax NOW Flu A and B and direct fluorescent assay in comparison with a composite of viral culture or reverse transcription polymerase chain reaction for detection of influenza infection during the 2006 to 2007 season",
    abstract = "The Binax NOW Flu A and Flu B (Binax NOW), direct fluorescent assay (DFA), and viral culture were evaluated and compared with a composite of viral culture or reverse transcription polymerase chain reaction (RT-PCR). Participants with medically attended acute respiratory illness were identified through active surveillance during the 2006 to 2007 season, and consenting individuals (n = 932) were tested for influenza by culture and RT-PCR. Physicians ordered a rapid antigen test (Binax NOW [n = 73] or DFA [n = 70]) according to their clinical judgment. The Binax NOW detected 11 of 18 influenza infections (sensitivity, 61{\%}; 95{\%} confidence interval [CI], 36-83{\%}), whereas DFA detected 17 of 21 influenza infections (sensitivity 81{\%}, 95{\%} CI, 58-95{\%}). Compared with culture/RT-PCR, specificity of both Binax NOW and DFA was 100{\%}. During the 2006 to 2007 influenza season, DFA and Binax NOW demonstrated high specificity but failed to identify a substantial proportion of influenza infections.",
    keywords = "Binax NOW, Direct fluorescent assay, Influenza virus, Rapid test, Sensitivity, Specificity",
    author = "Mahbubur Rahman and Vandermause, {Mary F.} and Kieke, {Burney A.} and Belongia, {Edward A.}",
    year = "2008",
    month = "10",
    doi = "10.1016/j.diagmicrobio.2007.10.012",
    language = "English (US)",
    volume = "62",
    pages = "162--166",
    journal = "Diagnostic Microbiology and Infectious Disease",
    issn = "0732-8893",
    publisher = "Elsevier Inc.",
    number = "2",

    }

    TY - JOUR

    T1 - Performance of Binax NOW Flu A and B and direct fluorescent assay in comparison with a composite of viral culture or reverse transcription polymerase chain reaction for detection of influenza infection during the 2006 to 2007 season

    AU - Rahman, Mahbubur

    AU - Vandermause, Mary F.

    AU - Kieke, Burney A.

    AU - Belongia, Edward A.

    PY - 2008/10

    Y1 - 2008/10

    N2 - The Binax NOW Flu A and Flu B (Binax NOW), direct fluorescent assay (DFA), and viral culture were evaluated and compared with a composite of viral culture or reverse transcription polymerase chain reaction (RT-PCR). Participants with medically attended acute respiratory illness were identified through active surveillance during the 2006 to 2007 season, and consenting individuals (n = 932) were tested for influenza by culture and RT-PCR. Physicians ordered a rapid antigen test (Binax NOW [n = 73] or DFA [n = 70]) according to their clinical judgment. The Binax NOW detected 11 of 18 influenza infections (sensitivity, 61%; 95% confidence interval [CI], 36-83%), whereas DFA detected 17 of 21 influenza infections (sensitivity 81%, 95% CI, 58-95%). Compared with culture/RT-PCR, specificity of both Binax NOW and DFA was 100%. During the 2006 to 2007 influenza season, DFA and Binax NOW demonstrated high specificity but failed to identify a substantial proportion of influenza infections.

    AB - The Binax NOW Flu A and Flu B (Binax NOW), direct fluorescent assay (DFA), and viral culture were evaluated and compared with a composite of viral culture or reverse transcription polymerase chain reaction (RT-PCR). Participants with medically attended acute respiratory illness were identified through active surveillance during the 2006 to 2007 season, and consenting individuals (n = 932) were tested for influenza by culture and RT-PCR. Physicians ordered a rapid antigen test (Binax NOW [n = 73] or DFA [n = 70]) according to their clinical judgment. The Binax NOW detected 11 of 18 influenza infections (sensitivity, 61%; 95% confidence interval [CI], 36-83%), whereas DFA detected 17 of 21 influenza infections (sensitivity 81%, 95% CI, 58-95%). Compared with culture/RT-PCR, specificity of both Binax NOW and DFA was 100%. During the 2006 to 2007 influenza season, DFA and Binax NOW demonstrated high specificity but failed to identify a substantial proportion of influenza infections.

    KW - Binax NOW

    KW - Direct fluorescent assay

    KW - Influenza virus

    KW - Rapid test

    KW - Sensitivity

    KW - Specificity

    UR - http://www.scopus.com/inward/record.url?scp=51649115039&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=51649115039&partnerID=8YFLogxK

    U2 - 10.1016/j.diagmicrobio.2007.10.012

    DO - 10.1016/j.diagmicrobio.2007.10.012

    M3 - Article

    VL - 62

    SP - 162

    EP - 166

    JO - Diagnostic Microbiology and Infectious Disease

    JF - Diagnostic Microbiology and Infectious Disease

    SN - 0732-8893

    IS - 2

    ER -